Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
2017 · The Lancet · 1,400 citations
https://doi.org/10.1016/s0140-6736(17)33297-x